Why the study?
ACS remains a leading cause of cardiovascular morbidity and mortality, requiring timely identification, risk stratification, and intervention in patients presenting with chest pain.
Design
Review
Authors
Loading...
Periodic updates to chest pain pathways may aid ACS risk stratification; leaves open prospective validation of emerging tools.
This review highlights the 20-year evolution and future directions of an institutional chest pain clinical pathway for timely identification and risk stratification of acute coronary syndromes.
Zilinyi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: